Sun Life Financial’s commitment to its Asia operations, bolstering asset management divisions, expansion in the U.S. market, and solid financial footing paint a promising picture for future growth.
The Fortunes in Earnings
Sun Life has outperformed the Zacks Consensus Estimate for earnings in three out of the last four quarters, achieving an impressive average beat of 3.32%.
Shifting North: Positive Estimate Revisions
Over the preceding 60 days, there has been a noteworthy uptick in the Zacks Consensus Estimate for Sun Life’s 2024 and 2025 earnings – climbing 20% and 2% respectively, signaling growing optimism among analysts.
Strength in Numbers: Zacks Rank & Price Momentum
In the past year, Sun Life has seen an 18.9% surge in stock value, outpacing the industry growth of 31.6%. The company proudly flaunts a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Glimmering Growth Prospects
Projections suggest a robust 8% year-over-year increase in Sun Life’s 2024 earnings per share compared to 2023, while the anticipation for 2025 foresees a 7.3% boost from the estimate for 2024.
Building Momentum: Business Tailwinds
Sun Life’s strategic focus on the flourishing Asia market, with its superior returns compared to North America, has been paying dividends. The Asian segment’s share of the earnings pie has skyrocketed from 8% to 21%, showcasing solid growth.
The Canadian insurance giant is reshaping its business mix to prioritize products that demand lesser capital and ensure steadier earnings. By sharpening its competitive edge, Sun Life aims to solidify its position as a key player, especially in the voluntary benefits sector.
Investing wisely in Asset Management, Sun Life is tapping into private fixed-income, mortgages, and real estate opportunities. This move promises higher returns on equity, lower capital requirement, and potentially enhanced earnings.
Operational efficiency has been a cornerstone in Sun Life’s journey to fortify its financial position. With a commitment to allocate 40-50% of its earnings in dividends over the medium term, the company is demonstrating its prowess. Proactively embracing fee-based, capital-light enterprises, Sun Life has reaffirmed its medium-term ROE target of 18%.
Bolstering this strong foundation is SLF’s impressive Value Score of A, marking it as a prime choice for value investors. A historical analysis reveals that stocks with an A or B Value Score coupled with a Zacks Rank of #1 or #2 stand out as excellent investment prospects.
Exploring Options: Alternatives in the Industry
For investors seeking diversification in the insurance sector, other viable options to consider alongside Sun Life Financial (SLF) are Manulife Financial Corporation (MFC), Primerica Inc. (PRI), and Axis Capital Holdings Limited (AXS), all currently holding a Zacks Rank #2.
Manulife has consistently exceeded earnings expectations over the past four quarters, yielding an average surprise of 7.01% and witnessing a 35.6% growth in its shares in the last year.
Similarly, Primerica boasts an average earnings surprise of 3.1% across four quarters and a substantial 52.7% hike in its share value in the previous year.
Axis Capital has been a consistent performer, surpassing earnings estimates in all four recent quarters with an average surprise of 102.57% and registering a 19.2% increase in share value over the year.
Insider Track: Unveiling the Best Stocks for the Future
Exclusive insights: Financial experts have hand-picked 7 promising stocks from a pool of 220 Zacks Rank #1 Strong Buys. These top-tier selections are labeled as “most likely for early price pops.”
Since 1988, this curated list has outperformed the market by over 2 times, boasting an impressive yearly average gain of +24.2%. Take a closer look at these chosen few for potential early rewards.
Axis Capital Holdings Limited (AXS) : Free Stock Analysis Report
Manulife Financial Corp (MFC) : Free Stock Analysis Report
Primerica, Inc. (PRI) : Free Stock Analysis Report
Read the full article on Zacks.com here.
Investment insights are indicative of the author’s viewpoint and may not align with the opinions of Nasdaq, Inc.
